Literature DB >> 729438

Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus.

J S Christiansen.   

Abstract

In order to evaluate a possible relation between cigarette smoking and prevalence of diabetic microangiopathy, a series of 180 consecutive patients suffering from insulin-dependent juvenile-onset diabetes mellitus with different durations of disease (60 patients each with diabetes for 10 to 19 years, 20 to 29 years, and 30 to 39 years, respectively) were examined for clinical signs of retinopathy, nephropathy, and peripheral neuropathy. The results were compared with the patients' previous and actual smoking habits. Cigarette smoking was defined as daily smoking of at least ten cigarettes for one year or more. Smoking habits of the total diabetic sample were not significantly different from those of a nondiabetic control sample. However, a decline in the number of cigarette smokers and a rising number of ex-smokers were noted with increasing duration of diabetes. In comparing smokers and nonsmokers, no difference was found in the prevalence of peripheral neuropathy, background retinopathy, and proliferative retinopathy. However, the prevalence of nephropathy (persistent proteinuria) was significantly higher (p less than 0.05) among these patients who were or had been cigarette smokers. Thus, cigarette smoking might be considered a risk factor for the development of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729438     DOI: 10.2337/diacare.1.3.146

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Nicotine, smoking, podocytes, and diabetic nephropathy.

Authors:  Edgar A Jaimes; Ming-Sheng Zhou; Mohammed Siddiqui; Gabriel Rezonzew; Runxia Tian; Surya V Seshan; Alecia N Muwonge; Nicholas J Wong; Evren U Azeloglu; Alessia Fornoni; Sandra Merscher; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-18

2.  Modern management of the insulin dependent diabetic.

Authors:  R Tattersall
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

3.  Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria.

Authors:  R P Dullaart; L D Dikkeschei; H Doorenbos
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

4.  Alcohol: another risk factor for diabetic retinopathy?

Authors:  R J Young; D K McCulloch; R J Prescott; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

5.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

6.  HLA antigens and other risk factors in the development of retinopathy in type 1 diabetes.

Authors:  R S Gray; I R Starkey; S Rainbow; A B Kurtz; A Abdel-Khalik; S Urbaniak; R A Elton; L J Duncan; B F Clarke
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

7.  Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.

Authors:  A R Andersen; J S Christiansen; J K Andersen; S Kreiner; T Deckert
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

8.  Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.

Authors:  F Giorgino; L Laviola; P Cavallo Perin; B Solnica; J Fuller; N Chaturvedi
Journal:  Diabetologia       Date:  2004-05-29       Impact factor: 10.122

9.  Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors.

Authors:  T Jensen; K Borch-Johnsen; A Kofoed-Enevoldsen; T Deckert
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

10.  Factors protective against retinopathy in insulin-dependent diabetics free of retinopathy for 30 years.

Authors:  T Dornan; J I Mann; R Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.